{"name":"R&R Inc.","slug":"r-r-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOeDJRNEEwZkI5ZEtMWjQ3ODR5QTR0cXB5czQwTHdTSWNCMUFXemNuZmY4X1Y3VUVqRFkwdWZ5TFppM1J5ZlhHelhmY05uTEhIR2w4UzlHYThlTmJZbHVpX3I0YUFPcXFOZV9PMkVmNVVGWkY5YXFUVklZRHNCdUhKWkk3aVhRM2VUY21mR0VzaDlXX0xTSXdua21yU3VlQS1Nb1ZPc2JfdkZ3dUw3S1hVWTVHSHlyT21rNlVwNGtZeTd6MHlyUThaUFdpNW9BNXJ1c0FuLW95Y0Nyc0FCcDkyVkJLRzhHODhoa1FJUXdvc0ZiYjlyOGY0bktFSngxSXVBWk9mWmR4bmNSQkdLTmVCUnV0a1Zfa3M?oc=5","date":"2026-04-06","type":"pipeline","source":"GlobeNewswire","summary":"Shareholders of Richtech Robotics Inc. Should Contact Levi - GlobeNewswire","headline":"Shareholders of Richtech Robotics Inc. Should Contact Levi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOc19kY0FxdjRNb3BZQlVnZ0F0dnYtODNEUWM2UjVQZlJBZEJQYXYwT2hYczZyRXUyZTRWUVRBWVZJQ2Mtc0E4NTBmZUhDRG9Wc1MxSFNVOUZ2cWpNRGdKUzRES2VweDFiT2V5VXU5SW1wN3JqNHlCVHlKRjNMQUZ4am9Od3JESXlwa3hjVFNFMnc2elBKZlkzWmR0am1UUDZxdUZiVTdjRVB2YU5wWEl6N3g2SUhZRHVrMXRoVjBzVjVpRURNYXhTQ0pmTk9MMUVnT01RbC1BbjdwRzVpQzBEdjF1LVBSNHp3MVYzUDZ0STE0bXM3Z05xaGxreXhyTVRPenJDSVlVYVM5RW5xTVE?oc=5","date":"2026-04-02","type":"pipeline","source":"GlobeNewswire","summary":"RR Investors Have Opportunity to Lead Richtech Robotics Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire","headline":"RR Investors Have Opportunity to Lead Richtech Robotics Inc. Securities Fraud Lawsuit with the Schall Law Firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxPWEdWSXluWHVLUUJVTVNCVDZlRnNHXzI5SmQ2OG9xMkliT3A5X1BmUFZxZ1hsai11clJMc0V2ek5qOWdWTjlORmJFLXZDNjhvMkpJcTN5U2Q5NXpMeTVNT3VMU2M4M1VJTTRTdk5STVFaV3hGNDlsYmhtd0hUSHp2UmxoLVdQQnpUSkd6X1BFSjBLMk1aRloyX2pmeW00ZDVGQ0hPeFJTX1ZBM1EyaTU4VzNfVkhBOGVnS2VscDRZNFFLRUJyY2dZN0ZKaGp3bWZIWEpPcVZ1WmdTY1RpN2h4UmRoeEJBemhRdVJJcU9TemR1M0FSOHVXeWxxYk5SbG5XalVJa0ZzYXkyZjlEQjU4bXYtRC1EbjRzQlAtVG1qR0lqMlNt?oc=5","date":"2026-03-21","type":"pipeline","source":"Tribune India","summary":"MIDC Signs Agreement with MILeS City, Subsidiary of Ramky Infrastructure Ltd, to Develop Rs INR 3,000 Cr High-tech Pharmaceutical Park in Raigad, Maharashtra - Tribune India","headline":"MIDC Signs Agreement with MILeS City, Subsidiary of Ramky Infrastructure Ltd, to Develop Rs INR 3,000 Cr High-tech Pharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOY2x4WnZZOFJhUGsxWHFSRFpUeDNSdDl5cm5pODUxTUhRMXRzc3RlZDRwYnBiT2cwVlkyck1qVEFTa005VW1OejBBd0NRTURPRjZ0cG1ndkM2R2N5RUd1eThNT0pIaHJxNG9wRGFWTHpoN0NQVlpNY1FqdDdZQW12RkpnRjZyOWt4ZU9HcS1OMkpvVS1zZVJKSS1ZLTRGNlQ5a0RyUUpqbDRxSGZ0c3BxYWNPZGF4b1pKaDdsMFVOdUdJUXNRV0lXMVZxV3dtS0JCWTczWHROWmY4SThDY3pmQnpuTTJWS3lMMENqX2Y5RjFQbnpLRG5RMjZnaDBRUnFseF9XZzg0aEpaRGdhbXc?oc=5","date":"2026-03-17","type":"pipeline","source":"prnewswire.com","summary":"RR Shareholder Alert: Richtech Robotics Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - prnewswire.com","headline":"RR Shareholder Alert: Richtech Robotics Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPbHhPd0pQS1o1Y3lyRG1sQ3FqZXNPeTI5SWlMZ3ZwcVlKOGVyQl90LVc2MndjbFNFRE55anFEMTdqUDZZOUlIVUNzNWxQT25GeUVWV0huMERJMkZEdmtpbWJ4MDJZRklRVVlycTZfRk5YS28xaHNqaThzNENRak5feWIwanFEenRVY2VkVGc2MmpReElub09OQ0VCM202V0ZKNWo1eFEySFMtSDEyMUVpY0dXVUVyQ19lNURPR1NsNVdfZUgwMWowQW9XbVJSdnY2RGFjQW5vNkJ4R3NIZ0lQcnRQSWhBRE5XVDloYm5MTW1YRVV3Y1dLLU0zZzZzN1p0?oc=5","date":"2026-02-02","type":"pipeline","source":"businesswire.com","summary":"EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Richtech Robotics Inc. Investors – RR - businesswire.com","headline":"EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Richtech Robotics Inc. Investors – RR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxQNnlQcnoyZ00wSzlCSXpFTE12dDRyUHlJRF8xaEFKVjFUZllLUFBFNWtZcGU3NnR3SXdVejZlSUUwYktSa3gtNlV4cTBCbTZmYmVTdTh3TGVqRjlJYlpnMXczX2w5NENaclN0cFNUdk9ZUVlLMi1kWnFkbnQzbEFvYW1lMlJQSUVsb2ZIbE1fQ1VweGNsTExpdEs1RTN2bndHbVAyMFp0YUtkdzdBVXBTVGRodEkyakwtSzAycDIxRF9hejFDT0lWNGlaam1sTTIwWHdmR2FXc2xpc3E1RHZPQ3lKUWVSRzJFMTZhOV9FU2tnc2U4Z203Ym41YjVrbHFQbDY0?oc=5","date":"2026-01-29","type":"pipeline","source":"businesswire.com","summary":"Rosen Law Firm Encourages Richtech Robotics Inc. Investors to Inquire About Securities Class Action Investigation – RR - businesswire.com","headline":"Rosen Law Firm Encourages Richtech Robotics Inc. Investors to Inquire About Securities Class Action Investigation – RR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFByTXVSTUFva01hbFhQMTJTeHVJWDQ0NnFaYURPOE43MFVMREJXUDlIWHJIRld0bWE5d3JkQmtocWgtMS1YMHYwVkVYbmFVaVlJZzVNb2NQN1BxRWNuWWU4Qkd2TndacDc3Z05nZXY4T2ljc0QxSFR5cEZJNTA?oc=5","date":"2026-01-05","type":"pipeline","source":"StocksToTrade","summary":"Dex Bot Showcase: A Game Changer? - StocksToTrade","headline":"Dex Bot Showcase: A Game Changer?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNaExBYjlzaEp5alRMbURSTlpGeTRDaWxVSkhCZ2pBUVQwWk9FQVYtSFVzYkVZOFFTaW9hMUlOOENRSWNWcXV6b0p4WnBWYUVpTTJnMDJXVkF1Y0lVdDV0UzNVWWVmQi02TlRyNy1EdjdlWGs5c1dwckpoVnlWN0VFbVdGY0pkZWxkMkFSY09YLWFaRVFhV0JtaE14dkk4NGJ0ZkdZSmsyT0VIc3l4MWNkR2lpVGlpcVJ1SkREWUR1S0s0SUk?oc=5","date":"2025-12-16","type":"deal","source":"Proactive financial news","summary":"Rolls-Royce tops up returns with interim share buyback - Proactive financial news","headline":"Rolls-Royce tops up returns with interim share buyback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxQUGRaRW16UHZ3Vjd2ZV9NY1NWM29fTjRlQXctT1VyckUwZzVzSTBWWGxUZDFKYTBGSS0zMGRNdEp6WmE3bHJHOW04Y08xdWxVRXZCRUVtSEU0RjNyZWhWZnJDNXowOGdUeGZ1bms5dXJWZUVUY0Q5bkhVYTJvcnU1THRVR1pDUFJ6Vkl3LTJLTmVPdC1mTW9zTi1MM21uNjRkbTJIY09oeDNYeGQ5V0NxajRNMkFnQU5sQzZuRGtzVWRIMmY5Z21pTk5qbUhOcmhZVUUyd2c2clpsM0hOdEp0ZlF0NHlmTDNGR1c0eXNacFpXSGYtMlk5OTZETlFxZ2I0ZmNIcDRJRHktd214VTRURlNSS0N5RnlmQkJXMFRDc3U3ajNHbXc?oc=5","date":"2025-11-17","type":"regulatory","source":"prnewswire.com","summary":"Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology - prnewswire.com","headline":"Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Jour","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOd0xJM3BPeGh4RThSMG9QTjdFMGswLXJSalQ5V0Z1MzhnY3ZydXgyTEFzZ2cyRlg3UHNqZFhiZ2xyR0kxZkFUam8wcHBrUzZVOE5ZcFM5WUktWTFNX2VIbnhOQURVSTNiam14ZjJpWVlhSU03RE9tWHRGcEVyZzNHTUdSZlNsazExdmEybzBNSUtnRzF1NmhFaWhDWHVpZ0pmQkszUQ?oc=5","date":"2025-11-14","type":"regulatory","source":"Pharmaceutical Technology","summary":"Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy - Pharmaceutical Technology","headline":"Kura and Kyowa Kirin secure FDA go-ahead for targeted leukaemia therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMm9BT3pXQlJNbHJfdnFEYlNyQ1NVeHVlekpJLVRmbW9nOG1DQjYtSnk3S3pFQ0dubVFVTmRldkg0dlNUbzRBamFlREd5bVZaTFdDMlI3UXo2VnJhbTM2RWJ5dDRXRFFuT1FGWnJkdGZhUHF5U2dLc2lTVnZMblgwenpDYkRXTkU3SjByeWtCcEVCNVpFRmZMOTdMdWJvdkVFbHI3UG1WeWgwQjNSVzVUbDJsU0lkVENi0gG-AUFVX3lxTE1lOFpaVnV2VmJPVUdYMWN3UlNnVkc5THdsNjRTY3pRX2VLanFPNE1oWWVSWXo4Z2hicEZNWlhiZEw4X1ppSGViVjQxbnpyX24wTkxoZXYxY1FUOVlQbFFNblJvMVhXM0JDdWpCMmxIY0dYLWxtYWdhR2RLSFhoWlR2NmNQWXcwQjZXVml2elZESWhuX2VBWW1GTkNyb2tBY21teW5MOVBETDN4YllHZHN0UVBDRXhxX2V0TkpPQWc?oc=5","date":"2025-08-20","type":"pipeline","source":"Medical Dialogues","summary":"Rs 180 Crore Ozempic Fraud: LOC Issued Against Pharma Firm CEO - Medical Dialogues","headline":"Rs 180 Crore Ozempic Fraud: LOC Issued Against Pharma Firm CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPRmJEY0xtcTFLTFZTbzNNQXJxVEFyV1VOVFM5ODRMbkJEQm81MUJPVl94Wm1JSFlDRExwNG1RaWJDMFQxYUw5YlVzVHRjMVRtek5tZ3pYRkNtNzNqT2RSR09qbXBOcmY3Ty1WamhSWFlHVzlPVlhscXBZay12X2JVc1Zfa1ZnZkhOWVZ5dklPdmdEaHBsbVdnUU5lTHRCUDIweWdUSjlwcUFOTzhVd0pXWFhObEJMa0lFTmc?oc=5","date":"2025-07-15","type":"pipeline","source":"seekingalpha.com","summary":"Arcellx; Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market (ACLX) - seekingalpha.com","headline":"Arcellx; Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market (ACLX)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}